REN and hydrops fetalis: Therapeutic agents such as renin-angiotensin system (RAS) inhibitors (angiotensin-converting enzyme inhibitors (ACEi), angiotensin II receptor blockers (ARB), or mineralocorticoid receptor antagonists (MRA)) and beta-blockers are effective for suppression of chronic renin hyperactivity in the treatment of patients with chronic HF.